Cerus Corporation
NASDAQ:CERSMedical - Devices
+$0.08 today
- Market cap
- $391.79M
- Beta
- 1.77
- P/E (TTM)
- -53.8
- EPS (TTM)
- -$0.05
Volume 6.09M
Average 2.33M
CERS Net Income
Bottom-line profit after all expenses, interest, and taxes.
Cerus CorporationNASDAQ: CERS
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income remains negative
Q1 FY2026 net income was -$1.64M, compared with -$7.72M a year earlier. Trailing-twelve-month net income was -$9.55M.
Context
- Net income amounted to 7.6% of revenue in FY2025, down 4.0 pp from a year earlier.
- Net income grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of -$5.23M (+66.6%) for the fiscal year ending Dec 2026, a step up from the +25.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.64M+24.9% QoQ
- Last fiscal yearDec 2025
- -$15.63M+25.3% YoY
- LTMMar 2026
- -$9.55M+49.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +78.7% | +52.9% | -25.9 pp |
| 1 year | +25.3% | +66.6% | +41.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (15.63M) USD
- Year-over-year change
- +25.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (15.63M) | +25.3% |
| FY2024 | 2024-12-31 | (20.92M) | +44.2% |
| FY2023 | 2023-12-31 | (37.49M) | +12.4% |
| FY2022 | 2022-12-31 | (42.78M) | +21.3% |
| FY2021 | 2021-12-31 | (54.37M) | — |
Net Income vs competitors
How CERS compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +49.6% is the 2nd highest of 4, against a peer median of -19.1%.
- Net income amounts to 4.3% of revenue for CERS, versus a peer median of 7.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | €452.49M EUR | +52.1% | +27.8% | 6.1% | |
| LTM Jun 2026 | $168.96M USD | -19.1% | — | 33.0% | |
| LTM Jun 2026 | $96.29M USD | -41.1% | -5.5% | 7.1% | |
| LTM Mar 2026 | -$9.55M USD | +49.6% | — | 4.3% | |
| Peer median (excluding CERS) | — | -19.1% | +11.1% | 7.1% | |
Competitors are the stored peer set for CERS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 130.86M | 162.05M | 156.37M | 180.27M | 206.13M |
| Cost of Revenue | 63.48M | 74.95M | 69.97M | 80.75M | 95.85M |
| Gross Profit | 67.38M | 87.09M | 86.4M | 99.52M | 110.29M |
| Gross Margin | 51.5% | 53.7% | 55.3% | 55.2% | 53.5% |
| Research & Development | 63.69M | 64.11M | 67.64M | 58.91M | 65.72M |
| Selling, General & Admin | 81.29M | 83.34M | 75.52M | 75.89M | 80.91M |
| Operating Expenses | 116.32M | 121.18M | 116.45M | 113.75M | 146.63M |
| Depreciation & Amortization | 3.15M | 2.98M | 2.6M | 1.86M | 2M |
| EBITDA | (45.99M) | (33.52M) | (26.34M) | (10.02M) | (4.94M) |
| EBITDA Margin | -35.1% | -20.7% | -16.8% | -5.6% | -2.4% |
| Operating Income | (48.94M) | (34.08M) | (30.05M) | (14.23M) | (36.35M) |
| Operating Margin | -37.4% | -21.0% | -19.2% | -7.9% | -17.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.92M | 5.83M | 8.39M | 8.88M | 8.34M |
| Other Income / Expenses | (5.12M) | (8.26M) | (7.27M) | (6.53M) | 21.06M |
| Income Before Tax | (54.06M) | (42.34M) | (37.32M) | (20.76M) | (15.28M) |
| Pre-Tax Margin | -41.3% | -26.1% | -23.9% | -11.5% | -7.4% |
| Income Tax Expense | 319K | 488K | 325K | 205K | 354K |
| Net Income | (54.37M) | (42.78M) | (37.49M) | (20.92M) | (15.63M) |
| Net Margin | -41.6% | -26.4% | -24.0% | -11.6% | -7.6% |
| EPS (Basic) | (0.32) | (0.24) | (0.21) | (0.11) | (0.08) |
| EPS (Diluted) | (0.32) | (0.24) | (0.21) | (0.11) | (0.08) |
| Weighted Avg Shares | 171.28M | 176.55M | 180.27M | 184.56M | 190.59M |
| Weighted Avg Shares (Diluted) | 171.28M | 176.55M | 180.27M | 184.56M | 190.59M |
Cerus Corporation
NASDAQ:CERS
Intrinsic Alpha fair value
Locked
Current Price
$1.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.